desmopressin acetate ( ddavp ) has been advocated as efficacious in reducing mediastinal bleeding following cardiopulmonary bypass ( cpb ) , and has been shown to ameliorate platelet dysfunction ;
C0086135
desmopressin acetate
C0019080
bleeding